Artificial Intelligence

Aristotle Raises $5M Seed to Scale Voice-First AI Tutoring

Image
Aristotle Raises $5M Seed to Scale Voice-First AI Tutoring

San Francisco – September 19, 2026 -- Aristotle, a voice-first AI tutoring platform, has closed $5 million in seed funding led by True Ventures, with participation from Wicklow Capital and angel investors from Anthropic, OpenAI, Sierra, Ramp, and Cognition.

Closed beta logs 1,500 tutoring hours before nationwide launch

The startup is launching nationwide after a closed beta in which more than 1,000 students completed over 1,500 hours of one-on-one tutoring sessions. The platform targets students ages 13-18 across STEM subjects, standardized testing, and language learning.

Globee Awards Opens Nominations for 23rd Cybersecurity AI Honors

Image
Globee Awards Opens Nominations for 23rd Cybersecurity AI Honors

San Francisco – – September 19, 2026 -- The Globee Awards has opened nominations for its 23rd Annual Globee Awards for Cybersecurity, calling on organizations and professionals worldwide to submit artificial intelligence security achievements for evaluation.

Program targets both AI-driven defense and AI system protection

The awards accept entries covering two distinct fronts: the use of AI to strengthen cybersecurity operations, and the protection of AI systems, models, data, and infrastructure themselves. Eligible categories span AI-powered threat detection, fraud detection, identity security, automated incident response, vulnerability management, cloud security, security analytics, AI governance, model security, and agentic AI security.

DentScribe Launches Benchmark Exposing AI Dental Note Accuracy Risks

Image
DentScribe Launches Benchmark Exposing AI Dental Note Accuracy Risks

Sunnyvale, Calif. – September 19, 2026 -- DentScribe, an AI platform for dental documentation, released Dental AI SOAP Note Benchmark 1.0 and a companion white paper titled "Beyond Transcription" to expose how AI-generated clinical notes can misrepresent patient care despite reading smoothly.

Benchmark tests whether AI scribes preserve clinical accuracy across ten focused cases

The benchmark includes ten focused test cases plus two source-based cases built from de-identified clinical excerpts that retain the original scattered order of a real chairside conversation, including interruptions, corrections, and unrelated asides. Test instructions require each AI product to process the same encounter with one standard request, with the first output compared against expected clinical content. A passing note must include every essential fact, contain no invented or conflicting clinical detail, and be organized for direct clinical use.

NewsBreak Names Nicolas Zylberstein First Chief Business Officer

Image
NewsBreak Names Nicolas Zylberstein First Chief Business Officer

Mountain View, Calif. – September 19, 2026 -- NewsBreak has appointed Nicolas Zylberstein as its first Chief Business Officer, tasking him with commercial growth across the core NewsBreak platform and two new AI ventures, Nearby AI and NDot AI.

NewsBreak creates first-ever Chief Business Officer role to scale two AI businesses

The newly created position places Zylberstein over strategic growth for NewsBreak's flagship local news and life platform, which serves more than 40 million monthly active users across the U.S. He will also oversee commercialization of Nearby AI, an agentic local intent marketplace connecting consumers to local businesses, and NDot AI, a B2B media technology platform offering publishers audience growth, personalization, engagement and monetization tools.

ADLM Tells Regulators AI Lab Tools Must Meet Existing CLIA Standards

Image
ADLM Tells Regulators AI Lab Tools Must Meet Existing CLIA Standards

Washington – September 19, 2026 -- The Association for Diagnostics & Laboratory Medicine (ADLM) has formally recommended that artificial intelligence tools used in clinical laboratories remain subject to the same validation, quality-system, and monitoring requirements that govern traditional laboratory testing under the Clinical Laboratory Improvement Amendments (CLIA). The recommendation was submitted in a comment letter responding to a federal request for information on potential updates to CLIA, the regulatory framework that has governed U.S. clinical laboratory testing since 1992.

Alibaba-Backed Orange Lion Sports Launches Smartshot 2.0 with AI Line Calling

Image
Alibaba-Backed Orange Lion Sports Launches Smartshot 2.0 with AI Line Calling

Beijing – September 18, 2026 -- Orange Lion Sports, a company founded by Alibaba Group, unveiled Smartshot 2.0, an upgraded AI sports technology platform, at the Sports Services exhibition during the 2026 China International Fair for Trade in Services (CIFTIS), held September 9-13 in Beijing.

Six-camera Hawk-Eye system targets amateur tennis line-call disputes

The upgraded electronic line calling system uses a six-camera Hawk-Eye setup to deliver instant in/out calls on a large screen as soon as a ball lands, with adjustable audio announcements. The company positions the technology as a low-cost alternative for amateur tournaments that eliminates the need for additional line-judge labor.

Peak3 Unveils AI-Driven Delivery Lifecycle, Cuts Core System Costs 50%

Image
Peak3 Unveils AI-Driven Delivery Lifecycle, Cuts Core System Costs 50%

Singapore – September 18, 2026 -- Peak3 has launched Graphene Harness, an end-to-end AI-driven delivery lifecycle (AI-DLC) for insurance software, alongside Graphene v4, an AI-native evolution of its core platform, cutting end-to-end new-feature development and core system implementation costs by 50% where deployed.

Peak3 targets an 80% cost reduction within 18 to 36 months

The Singapore-based insurance software provider said the current 50% reduction already applies to clients using Graphene Harness, with timelines shortened accordingly. Peak3 builds and maintains Graphene on the Harness system itself and is now extending access to selected implementation partners, with client availability planned over the next 6 to 12 months.

Wealthbox Launches Claude Connector for Financial Advisor CRM Data

Image
Wealthbox Launches Claude Connector for Financial Advisor CRM Data

Providence, R.I. – September 18, 2026 -- Wealthbox, a CRM software provider for financial advisors, has become a launch partner for Claude for Financial Advisors, a new offering from Anthropic that embeds the Claude AI model into advisor workflow tools.

Wealthbox connector brings client history directly into Claude

The new Wealthbox connector for Claude includes prebuilt skills that let advisors pull client history, notes, and activity stored in Wealthbox directly into Claude's reasoning environment. Advisors can use the tool to prepare meeting agendas, organize post-meeting follow-up that saves back into Wealthbox, summarize recent client activity, draft client communications, and identify outstanding tasks.

WISDOM to Host AI-Focused Women in STEM Networking Event Oct. 8

Image
WISDOM to Host AI-Focused Women in STEM Networking Event Oct. 8

Allentown, Pennsylvania – September 18, 2026 -- Women in Science Demonstrating Outstanding Merits (WISDOM) will convene its third annual Connecting Our Talents: Women in STEM event on Oct. 8, 2026, at Lehigh University's Iacocca Conference Center, running from 2 p.m. to 8 p.m.

Event pairs Lehigh Valley students with industry professionals to address AI's growing role in STEM careers

The gathering will bring together college students from across the Lehigh Valley with STEM industry professionals for networking and project showcases. A new format element this year requires each student presenter to spend one minute explaining how they incorporated artificial intelligence into their work, or explaining why they did not.

EMD Serono Buys PostEra's AI-Designed Oral Fertility Drug Programs

Image
EMD Serono Buys PostEra's AI-Designed Oral Fertility Drug Programs

Boston – September 17, 2026 -- EMD Serono, Inc., the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has acquired two preclinical fertility drug programs from PostEra, a biotech firm built on artificial intelligence-driven small molecule discovery.

PostEra's Proton platform generated oral agonists targeting two hard-to-drug fertility receptors

The acquired programs target the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LHCGR), both used over two years by PostEra's AI platform Proton to design small molecule candidates for reproductive endocrinology. FSHR agonists were developed for ovarian stimulation in in vitro fertilization (IVF), while LHCGR agonists target male infertility and ovulation triggering in IVF protocols.